These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8548894)

  • 1. Myocardial rubidium-82 tissue kinetics assessed by dynamic positron emission tomography as a marker of myocardial cell membrane integrity and viability.
    vom Dahl J; Muzik O; Wolfe ER; Allman C; Hutchins G; Schwaiger M
    Circulation; 1996 Jan; 93(2):238-45. PubMed ID: 8548894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?
    Beanlands RS; deKemp R; Scheffel A; Nahmias C; Garnett ES; Coates G; Johansen HL; Fallen E
    J Am Coll Cardiol; 1997 Mar; 29(3):537-43. PubMed ID: 9060890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of
    Moody JB; Hiller KM; Lee BC; Poitrasson-Rivière A; Corbett JR; Weinberg RL; Murthy VL; Ficaro EP
    J Nucl Cardiol; 2019 Apr; 26(2):374-386. PubMed ID: 30809755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Washout of ⁸²Rb as a marker of impaired tissue integrity, obtained by list-mode cardiac PET/CT: relationship with perfusion/metabolism patterns of myocardial viability.
    Chien DT; Bravo P; Higuchi T; Merrill J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1507-15. PubMed ID: 21528386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ischemic and hibernating myocardium: feasibility of post-exercise F-18 deoxyglucose positron emission tomography.
    Marwick TH; MacIntyre WJ; Salcedo EE; Go RT; Saha G; Beachler A
    Cathet Cardiovasc Diagn; 1991 Feb; 22(2):100-6. PubMed ID: 2009557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability.
    Go RT; MacIntyre WJ; Saha GB; Cook SA; Neumann DR; Chen EQ; Underwood DA; Kaczur T
    Radiology; 1995 Jan; 194(1):151-5. PubMed ID: 7997543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization.
    vom Dahl J; Eitzman DT; al-Aouar ZR; Kanter HL; Hicks RJ; Deeb GM; Kirsh MM; Schwaiger M
    Circulation; 1994 Nov; 90(5):2356-66. PubMed ID: 7955194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
    Kalff V; Berlangieri SU; Van Every B; Rowe JL; Lambrecht RM; Tochon-Danguy HJ; Egan GF; McKay WJ; Kelly MJ
    Eur J Nucl Med; 1995 Jul; 22(7):625-32. PubMed ID: 7498223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET.
    Gould KL; Yoshida K; Hess MJ; Haynie M; Mullani N; Smalling RW
    J Nucl Med; 1991 Jan; 32(1):1-9. PubMed ID: 1988610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
    Marshall RC; Tillisch JH; Phelps ME; Huang SC; Carson R; Henze E; Schelbert HR
    Circulation; 1983 Apr; 67(4):766-78. PubMed ID: 6600659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
    Stankewicz MA; Mansour CS; Eisner RL; Churchwell KB; Williams BR; Sigman SR; Streeter J; Patterson RE
    J Nucl Med; 2005 Oct; 46(10):1602-9. PubMed ID: 16204709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders].
    Maes A; Nuyts J
    Verh K Acad Geneeskd Belg; 1997; 59(3):133-60. PubMed ID: 9490915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.
    Camici P; Araujo LI; Spinks T; Lammertsma AA; Kaski JC; Shea MJ; Selwyn AP; Jones T; Maseri A
    Circulation; 1986 Jul; 74(1):81-8. PubMed ID: 3486725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
    Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
    Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.